1. Home
  2. NTRA vs DTE Comparison

NTRA vs DTE Comparison

Compare NTRA & DTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$208.72

Market Cap

32.9B

Sector

Health Care

ML Signal

HOLD

Logo DTE Energy Company

DTE

DTE Energy Company

HOLD

Current Price

$144.21

Market Cap

28.2B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
DTE
Founded
2003
1903
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
32.9B
28.2B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
DTE
Price
$208.72
$144.21
Analyst Decision
Strong Buy
Buy
Analyst Count
14
12
Target Price
$253.79
$147.75
AVG Volume (30 Days)
1.1M
1.8M
Earning Date
02-27-2026
02-17-2026
Dividend Yield
N/A
3.31%
EPS Growth
N/A
N/A
EPS
N/A
6.67
Revenue
$2,116,676,000.00
$14,822,000,000.00
Revenue This Year
$33.95
$11.74
Revenue Next Year
$16.72
$4.10
P/E Ratio
N/A
$21.13
Revenue Growth
38.17
19.39
52 Week Low
$125.38
$122.85
52 Week High
$256.36
$143.79

Technical Indicators

Market Signals
Indicator
NTRA
DTE
Relative Strength Index (RSI) 35.85 70.64
Support Level $203.86 $134.03
Resistance Level $213.96 $142.53
Average True Range (ATR) 8.54 2.60
MACD -2.07 0.59
Stochastic Oscillator 23.88 92.05

Price Performance

Historical Comparison
NTRA
DTE

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About DTE DTE Energy Company

DTE Energy owns two regulated utilities in Michigan that contribute 90% of earnings. DTE Electric serves approximately 2.3 million customers in southeastern Michigan, including Detroit. DTE Gas serves 1.3 million customers throughout the state. In addition, DTE has nonutility businesses and investments including energy marketing and trading, renewable natural gas facilities, and on-site industrial energy projects.

Share on Social Networks: